Kitron AB in Sweden has entered into a new agreement with CellaVision AB which develops and sells image analysis based systems for the routine analysis of blood and other body fluids.
Kitron ASAs subsidiary, Kitron AB in Karlskoga, Sweden has entered into a new agreement with CellaVision AB which develops and sells image analysis based systems for the routine analysis of blood and other body fluids. The agreement spans for two years and involves manufacturing of CellaVision's analysis instruments of a worth of around SEK 25 million annually.
The new agreement will replace the previous agreement from 2005. The cooperation involves manufacturing of the analysis instrument CellaVision® DM96 and further development of the product's optics and optronics.
"Extensive experience, specialization, and a continuous strive to improve are qualities that make Kitron a partner who complements our core competences. Kitron understands the special demands that characterize our industry and affect the manufacturing of our products," says Yvonne Mårtensson, CEO of CellaVision.
"We are proud of CellaVision's continued confidence in us and our manufacturing of their products for clients worldwide. We are impressed by CellaVision's success in the market and are glad to be able to contribute with our competence in both manufacturing and development," says Johannes Lind, General Manager for Kitron Sweden.